Equillium (EQ) Net Equity Issued and Repurchased (2020 - 2025)
Equillium's (EQ) quarterly Net Equity Issued and Repurchased came in at -$137000.0 in Q4 2025, down 298.55% year-on-year from $69000.0 in Q4 2024, and down 115.22% on a QoQ basis from $900000.0 in Q3 2025.
Equillium (EQ) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends
Equillium (EQ) has 4 years of Net Equity Issued and Repurchased data on file, last reported at -$137000.0 in Q4 2025.
- On a quarterly basis, Net Equity Issued and Repurchased fell 298.55% year-over-year to -$137000.0 in Q4 2025; TTM through Dec 2025 was $818000.0, a 95.91% decrease from a year earlier, with the FY2025 full-year figure at $682000.0, up 326.25% from the prior year.
- Net Equity Issued and Repurchased for Q4 2025 stood at -$137000.0, down from $900000.0 in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for EQ reached as high as $55.0 million in Q1 2025 and fell as low as -$54.9 million in Q2 2025.
- Historically, Net Equity Issued and Repurchased has averaged $4.4 million across 3 years, with a median of $900000.0 in 2025.
- Across the five-year window, Net Equity Issued and Repurchased surged 1190.32% in 2021 and tumbled 298.55% in 2025, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $19.9 million in 2021, then plunged by 99.65% to $69000.0 in 2024, then tumbled by 298.55% to -$137000.0 in 2025.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were -$137000.0 in Q4 2025, $900000.0 in Q3 2025, and -$54.9 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Equillium | 258.99 Mn | 258.99 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -137,000.00 |
| Dec 31, 2025 | -137,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Sep 30, 2025 | 900,000.00 |
| Jun 30, 2025 | -54.95 Mn |
| Jun 30, 2025 | -54.95 Mn |
| Mar 31, 2025 | 55.00 Mn |
| Mar 31, 2025 | 55.00 Mn |
| Dec 31, 2024 | 69,000.00 |
| Dec 31, 2024 | 69,000.00 |
| Dec 31, 2021 | 19.91 Mn |
| Dec 31, 2021 | 19.91 Mn |
| Mar 31, 2021 | 10.00 Mn |
| Mar 31, 2021 | 10.00 Mn |
| Dec 31, 2020 | -27.66 Mn |
| Dec 31, 2020 | -27.66 Mn |
| Sep 30, 2020 | 7.30 Mn |
| Sep 30, 2020 | 7.30 Mn |
| Jun 30, 2020 | 25,000.00 |
| Jun 30, 2020 | 25,000.00 |